Allotment of ~1.71 crore equity shares at ₹750 each under rights issue
Fund Raising Committee approved allotment of ~1.71 crore equity shares at ₹750 per share (including premium of ₹748) in the rights issue.
By ScoutQuest · · 2 min read
- Shares Allotted
- ~1.71 crore equity shares
- Issue Price
- ₹750 per share (including premium of ₹748)
- Paid-up Capital / Total Shares
- rose from ~₹35.82 crore to ~₹39.23 crore; total shares now 19,61,67,952 of face value ₹2 each
Rights issue allotment completed
The Fund-raising Committee of Natco Pharma met on October 23, 2026 and approved the allotment of ~1.71 crore equity shares under the rights issue. The basis of allotment was finalised in consultation with the National Stock Exchange of India, the designated stock exchange.
Price and face value
- Each equity share was allotted at ₹750.
- That price includes a premium of ₹748 per equity share.
- The face value of each share is ₹2.
What changed in the share capital
- Paid-up equity share capital rose from ~₹35.82 crore to ~₹39.23 crore.
- The number of fully paid-up equity shares of face value ₹2 each went from 17,91,09,870 to 19,61,67,952.
- The difference is exactly the ~1.71 crore shares allotted.
What a rights issue means for a retail holder
In a rights issue, a company offers new shares to its existing shareholders, usually in proportion to their current holding, instead of selling them to the public. Shareholders who applied and paid have now been issued those shares. Because the total number of shares has gone up, each existing share now represents a slightly smaller slice of the company — this is called dilution. The money received by the company adds to its capital base as shown by the increase in paid-up capital above.
Sequence of events as stated
- September 9, 2026: the Board approved the offer and issue of equity shares on a rights basis.
- September 25, 2026: the company intimated the outcome of the Board meeting approving the terms of the issue.
- September 28, 2026: the Fund Raising Committee approved the Letter of Offer.
- October 23, 2026: the Committee approved the allotment, after which the paid-up capital and share count changed as described.
The company has said this information is available on its rights issue page on its website.
Also from Natco Pharma
Rights Issue period closes today; issue of up to Rs.12,794 millions approved at Rs.750 per share
22 Oct 2026
Carboplatin Injection, generic of Paraplatin, launched in the U.S. market
19 Oct 2026
Natco Pharma in focus after Abu Dhabi Investment Authority acquired 1.73 lakh shares
19 Oct 2026
More numbers
- Equity shares allotted1,70,58,082
- Issue price per equity share₹750
- Premium per equity share₹748
- Face value per equity share₹2
- Paid-up capital before allotment₹35,82,19,740
- Paid-up capital after allotment₹39,23,35,904
- Fully paid-up equity shares before allotment17,91,09,870
- Fully paid-up equity shares after allotment19,61,67,952
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.